The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
Zamzam Awida(Tel Aviv University), Drorit Neumann(Tel Aviv University), Sahar Hiram‐Bab(Tel Aviv University), Yankel Gabet(Tel Aviv University), Almog Bachar(Tel Aviv University), Michael Brines(Northwell Health), Hussam Saed(Tel Aviv University), Anton Gorodov(Tel Aviv University), Nathalie Ben‐Califa(Tel Aviv University), Albert Kolomansky(Tel Aviv University), Maria Ibrahim(Tel Aviv University), Liad Graniewitz Visacovsky(Tel Aviv University), Tamar Liron(Tel Aviv University), Jennifer Ana Iden(Tel Aviv University)
Cited by 7
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654